A critical bottleneck remains the lack of robust biomarkers to assess myocardial redox status, predict therapeutic response, or stratify patients (Vukainovi et al., 2023)
IV therapy is not recommended for those with kidney disease, congestive heart failure, active infection, uncontrolled hypertension, or known allergy to infusion components
Womens bodies are under more scrutiny than ever before
For the treatment to be effective, it should also be used as a combination with exercise and a healthy, low-calorie diet
Exploring the role of nutraceuticals in major depressive disorder (MDD): rationale, state of the art and future prospects
During the pregnancy high progesterone blood concentrations are putting the break on prolactin